This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Priska Frei, Ph.D.
Scientist QC at Bachem AG
Speaker

Profile

Priska Frei studied Pharmaceutical Sciences. In 2018, she received her Ph.D. from the University of Basel (Switzerland) for her work on therapeutically promising carbohydrates. She then proceeded to work at the Institute of Legal Medicine of Basel-Stadt, where she developed analytical methods for the detection of psychoactive substances in biological matrices. In the beginning of 2022, she joined Bachem as scientist in the analytical development. Her responsibilities focus on chromatographic method development for peptide NCE projects.

Agenda Sessions

  • Analytical Procedure Development for Novel Peptides: From Column Screening to GMP Releases

    11:45am